Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS first to mechanise agricultural technique
2006-05-09

    

Small farmers from Thaba `Nchu were the biggest group attending the farmers day at the UFS Paradys experimental farm.  From the left are Mr David Motlhale (a small farmer from Thaba 'Nchu), Prof Leon van Rensburg (lecturer at the UFS Department of Soil, Crop and Climate Sciences and project leader), Mr Nhlonipho Nhlabatsi (Agricultural Research Council, Glen), Ms Meisie Mthethwa (small farmer from Bloemspruit).  In front is Mr Patrick Molatodi (chairperson of the Tswelopele Small Farmer Association).
 

 

Some of the participants of the farmers day at the UFS Paradys experimental farm were from the left Prof Leon van Rensburg (lecturer at the UFS Department of Soil, Crop and Climate Sciences and project leader, Mr Patrick Molatodi (chairperson of the Tswelopele Small Farmers Association) and Prof Herman van Schalkwyk (Dean: UFS Faculty of Natural and Agricultural Sciences).

UFS first tertiary institution in world to mechanise agricultural technique
The University of the Free State (UFS) is the first tertiary institution in the world to mechanise the in-field rain water harvesting technique on a commercial scale.

The technique was recently demonstrated to about 100 small farmers at the UFS Paradys experimental farm outside Bloemfontein. 

“With this technique rain water is channeled to the plant and in this way food security is increased.  The advantage of the technique for commercial farmers lies in the reduced cultivation of land.  Small farmers will benefit from this because they can now move out into the fields and away from farming in their back yards,” says Prof Leon van Rensburg, lecturer at the UFS Department of Soil, Crop and Climate Sciences and project leader.    

Rain water harvesting is an antique concept that was used by communities before the birth of Christ.  In South Africa the technique is mainly used in the plots of small farmers where they make surface structures by hand. 

"The technique is also used for the first time by the UFS on commercial scale by means of the cultivation of a summer crop on 100 ha at the Paradys experimental farm,” says Prof Leon van Rensburg,

Of the farmers who attended the farmers day most represented about 42 rural communities in the vicinity of Thaba ‘Nchu.  A group of seven from KwaZulu-Natal also attended the proceedings.  These small farmers can for example apply this technique successfully on the 250-300 ha communal land that is available in the Thaba ‘Nchu area. 

The project is funded by the UFS and the National Research Foundation (NRF) and the farmers’ day was funded by the Water Research Commission.   

Media release
Issued by: Lacea Loader
Media Representative
Tel:   (051) 401-2584
Cell:  083 645 2454
E-mail:  loaderl.stg@mail.uovs.ac.za
9 May 2006

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept